Wiley Bros. Aintree Capital, LLC Quest Diagnostics Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 27,594 shares of DGX stock, worth $3.78 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
27,594
Previous 11,656
136.74%
Holding current value
$3.78 Million
Previous $1.6 Million
136.82%
% of portfolio
0.05%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding DGX
# of Institutions
984Shares Held
98.6MCall Options Held
417KPut Options Held
227K-
Vanguard Group Inc Valley Forge, PA14MShares$1.91 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.49MShares$753 Million0.1% of portfolio
-
State Street Corp Boston, MA5.22MShares$716 Million0.03% of portfolio
-
Victory Capital Management Inc3.36MShares$461 Million0.48% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...